Cancel-Tassin, G. http://orcid.org/0000-0002-9583-6382
Roupret, M.
Pinar, U.
Gaffory, C.
Vanie, F.
Ondet, V.
Compérat, E.
Cussenot, Olivier http://orcid.org/0000-0002-9912-0533
Funding for this research was provided by:
Cepheid
Article History
Received: 23 October 2020
Accepted: 3 February 2021
First Online: 26 March 2021
Compliance with ethical standards
:
: Prof. Roupret reports personal fees from Cepheid, Roche, Janssen, Astellas, Ferring, Pfizer, MSD, and Arquer, outside the submitted work. Dr. Cancel-Tassin and Cécile Gaffory report that Cepheid has provided CeRePP, the institution that employs them, funding for the conduct of the study (for human resources and data collection) and kits for free. The other authors have nothing to disclose.
: This study was performed in line with the principles of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. In accordance with French law, the study protocol was approved by the Institutional Review Board (IRB) no. 00003835 (approval no. 2011-24NICB) and the processing of personal data was approved by the French data protection agency (<i>Commission Nationale de l'Informatique et des Libertés, CNIL</i>).
: In conformity with the Jardé law, all patients gave their oral informed consent before inclusion, after having been informed about the study.
: Data are available from the corresponding author upon request.